Biolife Solutions Inc financial data

Symbol
BLFS on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
3303 Monte Villa Parkway, Suite 310, Bothell, WA
State of incorporation
DE
Fiscal year end
December 31
Former names
CRYOMEDICAL SCIENCES INC (to 11/14/2002)
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 326 % +14.1%
Quick Ratio 102 % +16%
Debt-to-equity 17.2 % -26.7%
Return On Assets -5.18 % +67.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47M shares +2.11%
Common Stock, Shares, Outstanding 46.9M shares +3.85%
Entity Public Float 784M USD +1.29%
Common Stock, Value, Issued 47K USD +4.44%
Weighted Average Number of Shares Outstanding, Basic 46.1M shares +5.37%
Weighted Average Number of Shares Outstanding, Diluted 46.1M shares +5.37%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.91M USD -34.5%
Selling and Marketing Expense 9.61M USD -24.4%
General and Administrative Expense 40.5M USD -6.29%
Costs and Expenses 89.4M USD -9.98%
Operating Income (Loss) -7.13M USD +69.6%
Nonoperating Income (Expense) -4.3M USD -186%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.4M USD +38.1%
Income Tax Expense (Benefit) -38K USD -58.3%
Net Income (Loss) Attributable to Parent -20.2M USD +70.3%
Earnings Per Share, Basic -0.44 USD/shares +71.6%
Earnings Per Share, Diluted -0.44 USD/shares +71.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 95.4M USD +242%
Cash, Cash Equivalents, and Short-term Investments 39.3M USD -6.87%
Accounts Receivable, after Allowance for Credit Loss, Current 9.17M USD +16.1%
Inventory, Net 29M USD +6.81%
Assets, Current 149M USD +23.3%
Property, Plant and Equipment, Net 6.08M USD +6.94%
Operating Lease, Right-of-Use Asset 10.7M USD +55.2%
Intangible Assets, Net (Excluding Goodwill) 9.56M USD -20.3%
Goodwill 212M USD 0%
Assets 399M USD -3.21%
Accounts Payable, Current 3.57M USD +57.4%
Accrued Liabilities, Current 7.12M USD +7.49%
Contract with Customer, Liability, Current 103K USD +151%
Liabilities, Current 32.7M USD -22.4%
Deferred Income Tax Liabilities, Net 124K USD +8.77%
Operating Lease, Liability, Noncurrent 12.7M USD +46.3%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 50.6M USD -32.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 24K USD
Retained Earnings (Accumulated Deficit) -335M USD -6.41%
Stockholders' Equity Attributable to Parent 349M USD +3.33%
Liabilities and Equity 399M USD -3.21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.48M USD -65%
Net Cash Provided by (Used in) Financing Activities -952K USD -69.4%
Net Cash Provided by (Used in) Investing Activities -221K USD -108%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 46.9M shares +3.85%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.2M USD +25.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 445K USD -10.5%
Deferred Tax Assets, Valuation Allowance 58.3M USD +17.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 63.2M USD +12.9%
Operating Lease, Liability 14.2M USD -11%
Depreciation 700K USD -12.5%
Payments to Acquire Property, Plant, and Equipment 3.3M USD +126%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -20.2M USD +70.1%
Lessee, Operating Lease, Liability, to be Paid 17.3M USD -5.25%
Property, Plant and Equipment, Gross 10.4M USD +4.34%
Operating Lease, Liability, Current 1.51M USD +17.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.03M USD +2.33%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.35M USD -30.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +44.4%
Deferred Income Tax Expense (Benefit) 5K USD -61.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.04M USD +36.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.58M USD -2.71%
Deferred Tax Assets, Operating Loss Carryforwards 39.1M USD +10.1%
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 1.16M USD +21.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.64M USD +15.9%
Additional Paid in Capital 653M USD
Amortization of Intangible Assets 2.74M USD -22.2%
Depreciation, Depletion and Amortization 1.36M USD -20.7%
Share-based Payment Arrangement, Expense 16.5M USD -29%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%